BROMURO DE PANCURONIO PDF

Bromuro de Pancuronio by Gripe, released 23 October List of Drug Master Files (DMF) of Bromuro de pancuronio Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data: FDA Website. bromure de pancuronium, ChemIDplus. bromuro de pancuronio, ChemIDplus. pancuronii bromidum, ChemIDplus. pancuronium bromide.

Author: Kazrataur Tugor
Country: Mali
Language: English (Spanish)
Genre: Automotive
Published (Last): 9 March 2018
Pages: 101
PDF File Size: 1.26 Mb
ePub File Size: 3.87 Mb
ISBN: 241-5-97855-549-6
Downloads: 98034
Price: Free* [*Free Regsitration Required]
Uploader: Virg

Nizatidine The therapeutic efficacy of Pancuronium can be decreased when used in combination with Nizatidine.

Morphine The bromudo or severity of adverse effects can be increased when Morphine is combined with Pancuronium. Levobetaxolol Pancuronium may increase the bradycardic activities of Levobetaxolol. Cyamemazine The risk or severity of adverse effects can be increased when Pancuronium is combined with Cyamemazine.

Fendiline Fendiline may increase the neuromuscular blocking activities of Pancuronium.

Mephedrone The risk or severity of Tachycardia can be increased when Pancuronium is combined with Mephedrone. Chloral hydrate The risk or severity of adverse effects can be increased when Pancuronium is combined with Chloral hydrate. Acyclovir The risk or severity of adverse effects can be increased when Acyclovir is combined with Pancuronium. Diphenhydramine The therapeutic efficacy of Pnacuronio can be decreased when used in combination with Pancuronium. Demeclocycline The therapeutic efficacy of Pancuronium can be increased when used in combination with Demeclocycline.

Paancuronio Lercanidipine may increase the neuromuscular blocking activities of Pancuronium.

Bromuro de pancuronio | API DMFs | US Drug Master File (DMF) Details |

Carbinoxamine The risk or severity of adverse effects can be increased when Carbinoxamine is combined with Pancuronium. Fluphenazine The risk or severity of adverse effects can be increased when Fluphenazine is combined with Pancuronium. Meprobamate The risk or severity of adverse effects can be increased when Meprobamate is combined with Pancuronium. Dichlorvos The therapeutic efficacy of Pancuronium can be decreased when used in combination with Dichlorvos.

  7808CT DATASHEET PDF

Available for Android and iOS devices. Clenbuterol The risk or severity of Tachycardia can be increased when Pancuronium is combined with Clenbuterol.

Pancuronium – DrugBank

Bufylline The therapeutic efficacy of Pancuronium can be decreased when used in combination with Bufylline. Oxazepam The risk or severity of adverse effects can be increased when Oxazepam is combined with Pancuronium. Ketobemidone The risk or severity of adverse effects can be increased when Pancuronium is combined with Ketobemidone.

Midodrine The risk or severity of Tachycardia can be increased when Midodrine is combined with Pancuronium. Lincomycin The therapeutic efficacy of Pancuronium can be increased bromuuro used in combination with Lincomycin.

Aclidinium The risk or severity of adverse effects can be increased when Pancuronium is combined with Aclidinium. Aminophylline The therapeutic efficacy of Bromurl can be decreased when used in combination with Aminophylline.

Methyclothiazide The serum concentration of Methyclothiazide can be increased when it is combined with Pancuronium. Cortivazol The risk or severity of myopathy and weakness can be increased when Pancuronium is combined with Cortivazol.

Translation of “pancuronium bromide” in Spanish

Cinazepam The risk or severity of adverse effects can be increased when Pancuronium is combined with Cinazepam. Dexamethasone The risk or severity of myopathy and weakness can be increased when Pancuronium is combined with Dexamethasone. Doramectin The risk or severity of adverse effects can be increased when Pancuronium is combined with Doramectin. Imagabalin The risk or severity of adverse effects can be increased when Pancuronium is combined with Imagabalin.

Clorazepate The risk or severity of adverse effects can be increased when Clorazepate is combined with Pancuronium. Caroverine Caroverine may increase the neuromuscular blocking activities of Pancuronium. Lithium succinate The therapeutic efficacy of Pancuronium can be increased when used in combination with Lithium succinate.

Fluperolone The risk or severity of myopathy and weakness can be increased when Pancuronium is combined with Panucronio. Adinazolam The risk ds severity of adverse effects can be increased when Adinazolam is combined with Pancuronium. Home International Pancuronio bromuro Print Share. Deacetylbisacodyl The therapeutic efficacy of Deacetylbisacodyl can be decreased when used in combination with Pancuronium.

  ALGORITMO 3DES PDF

Ephedrine Pancuronium may increase panucronio neuromuscular blocking activities of Ephedrine. Eslicarbazepine The risk or severity of adverse effects can be increased when Pancuronium is combined with Eslicarbazepine.

Ginkgo biloba The therapeutic efficacy of Pancuronium can be decreased when used in combination with Ginkgo biloba.

This type of neuromuscular block is usually antagonized by anticholinesterase agents. Clopidogrel The risk or severity of adverse effects can be increased when Clopidogrel is combined with Pancuronium.

Cyclandelate Cyclandelate may increase the neuromuscular blocking activities of Pancuronium. Methylphenobarbital The therapeutic efficacy of Methylphenobarbital can be decreased when used in combination with Pancuronium. Chlorphenamine The risk or severity of adverse effects can be increased when Chlorphenamine is combined with Pancuronium. Brotizolam The risk or severity of adverse effects can be increased when Pancuronium is combined with Brotizolam.

Octopamine The risk or severity of Tachycardia can be increased when Pancuronium is combined with Octopamine. Benzoic Pancuroniio The therapeutic efficacy of Benzoic Acid can be decreased when used in combination with Pancuronium. Alosetron The risk or bbromuro of adverse effects can be increased when Alosetron is combined with Pancuronium.

Bentazepam The risk or severity of adverse effects can be increased when Pancuronium is combined with Bentazepam. Mesoridazine The risk or severity of adverse effects can be increased when Mesoridazine is combined with Pancuronium.